BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23829430)

  • 1. In silico target predictions: defining a benchmarking data set and comparison of performance of the multiclass Naïve Bayes and Parzen-Rosenblatt window.
    Koutsoukas A; Lowe R; Kalantarmotamedi Y; Mussa HY; Klaffke W; Mitchell JB; Glen RC; Bender A
    J Chem Inf Model; 2013 Aug; 53(8):1957-66. PubMed ID: 23829430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space.
    Koutsoukas A; Paricharak S; Galloway WR; Spring DR; Ijzerman AP; Glen RC; Marcus D; Bender A
    J Chem Inf Model; 2014 Jan; 54(1):230-42. PubMed ID: 24289493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous classifier fusion for ligand-based virtual screening: or, how decision making by committee can be a good thing.
    Riniker S; Fechner N; Landrum GA
    J Chem Inf Model; 2013 Nov; 53(11):2829-36. PubMed ID: 24171408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-target prediction using Winnow and naive Bayesian algorithms and the implications of overall performance statistics.
    Nigsch F; Bender A; Jenkins JL; Mitchell JB
    J Chem Inf Model; 2008 Dec; 48(12):2313-25. PubMed ID: 19055411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing global and local likelihood score thresholds in multiclass laplacian-modified Naive Bayes protein target prediction.
    Drakakis G; Koutsoukas A; Brewerton SC; Bodkin MJ; Evans DA; Bender A
    Comb Chem High Throughput Screen; 2015; 18(3):323-30. PubMed ID: 25747441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naïve Bayes classification using 2D pharmacophore feature triplet vectors.
    Watson P
    J Chem Inf Model; 2008 Jan; 48(1):166-78. PubMed ID: 18183968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Bayes affinity fingerprints" improve retrieval rates in virtual screening and define orthogonal bioactivity space: when are multitarget drugs a feasible concept?
    Bender A; Jenkins JL; Glick M; Deng Z; Nettles JH; Davies JW
    J Chem Inf Model; 2006; 46(6):2445-56. PubMed ID: 17125186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases.
    Nidhi ; Glick M; Davies JW; Jenkins JL
    J Chem Inf Model; 2006; 46(3):1124-33. PubMed ID: 16711732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using information from historical high-throughput screens to predict active compounds.
    Riniker S; Wang Y; Jenkins JL; Landrum GA
    J Chem Inf Model; 2014 Jul; 54(7):1880-91. PubMed ID: 24933016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target prediction utilising negative bioactivity data covering large chemical space.
    Mervin LH; Afzal AM; Drakakis G; Lewis R; Engkvist O; Bender A
    J Cheminform; 2015; 7():51. PubMed ID: 26500705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of machine learning to improve the results of high-throughput docking against the HIV-1 protease.
    Klon AE; Glick M; Davies JW
    J Chem Inf Comput Sci; 2004; 44(6):2216-24. PubMed ID: 15554692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian methods in virtual screening and chemical biology.
    Bender A
    Methods Mol Biol; 2011; 672():175-96. PubMed ID: 20838969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classifying molecules using a sparse probabilistic kernel binary classifier.
    Lowe R; Mussa HY; Mitchell JB; Glen RC
    J Chem Inf Model; 2011 Jul; 51(7):1539-44. PubMed ID: 21696153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Note on naive Bayes based on binary descriptors in cheminformatics.
    Townsend JA; Glen RC; Mussa HY
    J Chem Inf Model; 2012 Oct; 52(10):2494-500. PubMed ID: 22900941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PASS Targets: Ligand-based multi-target computational system based on a public data and naïve Bayes approach.
    Pogodin PV; Lagunin AA; Filimonov DA; Poroikov VV
    SAR QSAR Environ Res; 2015; 26(10):783-93. PubMed ID: 26305108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benchmark data sets for structure-based computational target prediction.
    Schomburg KT; Rarey M
    J Chem Inf Model; 2014 Aug; 54(8):2261-74. PubMed ID: 25084060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity selection of compounds based on 'protein affinity fingerprints' improves sampling of bioactive chemical space.
    Nguyen HP; Koutsoukas A; Mohd Fauzi F; Drakakis G; Maciejewski M; Glen RC; Bender A
    Chem Biol Drug Des; 2013 Sep; 82(3):252-66. PubMed ID: 23647865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale learning of structure-activity relationships using a linear support vector machine and problem-specific metrics.
    Hinselmann G; Rosenbaum L; Jahn A; Fechner N; Ostermann C; Zell A
    J Chem Inf Model; 2011 Feb; 51(2):203-13. PubMed ID: 21207929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiclass relevance units machine: benchmark evaluation and application to small ncRNA discovery.
    Menor M; Baek K; Poisson G
    BMC Genomics; 2013; 14 Suppl 2(Suppl 2):S6. PubMed ID: 23445533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of cytochrome P450 inhibitors and noninhibitors using combined classifiers.
    Cheng F; Yu Y; Shen J; Yang L; Li W; Liu G; Lee PW; Tang Y
    J Chem Inf Model; 2011 May; 51(5):996-1011. PubMed ID: 21491913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.